Argenxs FcRn inhibitor Vyvgart (Efgartigimod), approved in December 2021, entered the billion-dollar club by 2023
Therapeutic strategies aiming at iron metabolism as a possible target in MDS and AML can be roughly distributed in four approaches: reduction of iron required for cellular functions via iron chelation, modulation of proteins involved in iron metabolism, induction of ferroptosis und exploitation of iron proteins for the delivery of antileukemic drugs ( Figure 3 )
Clinical studies examining GHK-Cu applications for androgenetic alopecia have documented improvements in hair count, hair diameter, and overall scalp coverage
If youve been dealing with low energy, restless nights, or lingering inflammation, the root cause could be more than just stress or aging - it might be tied to glutathione deficiency symptoms that have gone unnoticed
Exposure to ATZ resulted in a dose-related drop in TAC, a reduction in GSH levels, and an increase in MDA content 67
Beyond appetite control, it boosts calorie-burning by stimulating insulin release helping your body use stored fat for energy